COSM Market Analysis
News & Sentiment
50 articles · sorted by datePage 1 of 3 · 50 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Fundamentals
Updated daily after market closeP/E ratio—Forward 21.14
EPS (TTM)$-0.660.0% YoY
Profit margin-30.4%HEALTHCARE
Market cap$13.4MMicro cap
Valuation
- Forward P/E
- 21.14
- PEG ratio
- 0.00
- P/B
- 0.66
- P/S (TTM)
- 0.19
- EV/EBITDA
- -1.60
Profitability & growth
- ROE (TTM)
- -92.3%
- Operating margin
- -12.2%
- Revenue growth YoY
- 30.7%
- Dividend yield
- —
- Beta
- 4.15
Last earnings
May 20, 2026 · Estimate $-0.04 · Reported $-0.36
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About Cosmos Health Inc.
Company profileCosmos Holdings Inc. is a vertically integrated pharmaceutical company. The company is headquartered in Chicago, Illinois.
Classification
- Sector
- Healthcare
- Industry
- Medical Distribution
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 5 AGIOU GEORGIOU STR, PILEA, THESSALONIKI
- Fiscal year end
- December
- Latest quarter
- Mar 31, 2026
Market cap$13.4M
Shares outstanding$62.1M
52W high$1.32
52W low$0.16
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent